Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.
Recall Number: D-1613-2014
Firm: Eugene Oregon, Inc.
Classification: Class I
Status: Terminated
Report Date: 20141008
Initiation Date: 20140505
Termination Date: 20150401
Reason for Recall
Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.
Product Description
Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.